拉夏贝尔(603157.SH)拟作价2.75亿元转让天津星旷98.04%份额
格隆汇6月21日丨拉夏贝尔(603157.SH)公布,公司全资子公司上海拉夏企业管理有限公司(“拉夏企管”)拟转让所持有的天津星旷企业管理咨询合伙企业(有限合伙)(“标的基金”)98.04%份额;交易对价为2.75亿元人民币。
此次转让是基于资本市场整体投资环境及公司实际情况决定的,有助于改善公司内部资产结构,为主营业务发展提供资金支持,进一步增强公司持续经营能力,符合公司的发展规划。
截止2018年底,标的基金的账面净值为2.36亿元;经公司财务部门测算,基于2018年12月31日止账面净值预计本次转让将对公司2019年度净利润产生约0.29亿元(扣除相关交易成本及税项后)的正面影响。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.